Nanotechnology: a reality for diagnosis of HCV infectious disease
Hepatitis C virus (HCV) is the primary etiologic agent of liver cirrhosis or hepatocellular carcinoma. HCV elevated infection rates are mostly due to the lack of an accurate and accessible screening and diagnosis, especially in low- and middle-income countries. Conventional HCV diagnostic algorithm consists of a serological test followed by a nucleic acid test. This sequence of tests is time consuming and not affordable for low-resource settings. Nanotechnology have introduced new promising tests for the diagnose of infectious diseases.
Source: Journal of Infection - Category: Infectious Diseases Authors: Sonia Arca-Lafuente, Paula Mart ínez-Román, Irene Mate-Cano, Ricardo Madrid, Verónica Briz Tags: Review Source Type: research
More News: Cancer & Oncology | Carcinoma | Cirrhosis | Hepatitis | Hepatitis C | Hepatocellular Carcinoma | Infectious Diseases | Liver | Liver Cancer | Nanotechnology | Urology & Nephrology